TABLE III. Association between isolates with (Group I) and without (Group II) discordant phenotype compared to molecular characterisation, with clinical and epidemiological variations of 47 cats assisted at the Laboratory of Clinical Research on Dermatozoonosis in Domestic Animals (INI)/Fiocruz, Rio de Janeiro - Brazil, 2010 to 2011.
Group I* | Group II** | |||
---|---|---|---|---|
Variables | n = 13 | n = 34 | p-value*** | |
General health | Good | 12 (92.3%) | 30 (88.2%) | 1 |
Regular | 1 (7.7%) | 4 (11.8%) | ||
Distribution of skin lesions | L1 | 1 (7.7%) | 14 (41.2 %) | 0.064 |
L2 | 7 (53.8%) | 9 (26.5%) | ||
L3 | 5 (38.5%) | 11 (32.3%) | ||
Respiratory signs | Present | 7 (53.8%) | 20 (58.8%) | 1 |
Absent | 6 (46.2%) | 14 (41.2%) | ||
Skin lesions | Present | 13 (100%) | 32 (94.1%) | - |
Absent | 0 | 2 (5.9%) | ||
Mucosal lesions | Present | 6 (46.2%) | 13 (38.2%) | 0.743 |
Absent | 7 (53.8%) | 21 (61.8%) | ||
Lymphadenomegaly | Present | 13 (100%) | 29 (85.3%) | - |
Absent | 0 | 5 (14.7%) | ||
Retroviruses (FIV/FeLV) | Positive | 5 (38.5%) | 7 (20.6%) | 0.268 |
Negative | 8 (61.5%) | 27 (79.4%) | ||
Functional rhinitis | Present | 7 (53.8 %) | 13 (38.2%) | 0.510 |
Absent | 6 (46.2%) | 21 (61.8%) | ||
Outcome | Favorable (Cure) | 3 (23.1%) | 14 (41.2 %) | 0.248 |
Unfavorable | 10 (76.9%) | 20 (58.8%) | ||
Castrated | Yes | 3 (23.1%) | 16 (47%) | 0.189 |
No | 10 (76.9%) | 18 (53%) | ||
Sex | Female | 11 (84.6%) | 24 (70.6%) | 0.464 |
Male | 2 (15.4%) | 10 (29.4%) |
isolates with discordant phenotype to molecular characterisation;
isolates without discordant phenotype to molecular characterisation;
p < 0.05.